John Rocha

John Rocha is the Chief Financial Officer of Regenacy Pharmaceuticals. Over his 20+ year career, John has served in a variety of finance and accounting roles for biopharmaceutical and healthcare companies including Zycos, MGI Pharma, Logical Therapeutics, Valeritas, and Artisan Pharma. Most recently, John was Senior Director of Finance & Administration at Acetylon Pharmaceuticals where he led all accounting, finance and administrative activities, and was a key member of the senior management team that sold Acetylon to Celgene. John began his career at Ernst & Young, and is a licensed CPA. He received his B.A. from Boston College and his MBA/MS from Northeastern University.